12/1
01:23 pm
omer
Omeros (NASDAQ:OMER) had its "buy" rating reaffirmed by analysts at D. Boral Capital. They now have a $36.00 price target on the stock.
Low
Report
Omeros (NASDAQ:OMER) had its "buy" rating reaffirmed by analysts at D. Boral Capital. They now have a $36.00 price target on the stock.
12/1
08:41 am
omer
Omeros Corporation Announces Closing of Asset Purchase and License Agreement with Novo Nordisk for Omeros' Clinical-Stage MASP-3 Inhibitor Zaltenibart (OMS906) [Yahoo! Finance]
Medium
Report
Omeros Corporation Announces Closing of Asset Purchase and License Agreement with Novo Nordisk for Omeros' Clinical-Stage MASP-3 Inhibitor Zaltenibart (OMS906) [Yahoo! Finance]
12/1
08:30 am
omer
Omeros Corporation Announces Closing of Asset Purchase and License Agreement with Novo Nordisk for Omeros’ Clinical-Stage MASP-3 Inhibitor Zaltenibart (OMS906)
Medium
Report
Omeros Corporation Announces Closing of Asset Purchase and License Agreement with Novo Nordisk for Omeros’ Clinical-Stage MASP-3 Inhibitor Zaltenibart (OMS906)
11/21
06:58 pm
omer
Omeros: Key Milestone Ahead, Risk-Averse Investors Should Avoid [Seeking Alpha]
Medium
Report
Omeros: Key Milestone Ahead, Risk-Averse Investors Should Avoid [Seeking Alpha]
11/17
01:19 pm
omer
Omeros Corporation (OMER) Q3 2025 Earnings Call Transcript [Seeking Alpha]
Medium
Report
Omeros Corporation (OMER) Q3 2025 Earnings Call Transcript [Seeking Alpha]
11/14
04:18 pm
omer
Omeros (NASDAQ:OMER) had its "buy" rating reaffirmed by analysts at D. Boral Capital. They now have a $36.00 price target on the stock.
High
Report
Omeros (NASDAQ:OMER) had its "buy" rating reaffirmed by analysts at D. Boral Capital. They now have a $36.00 price target on the stock.
11/11
09:31 am
omer
Omeros Corporation to Announce Third Quarter Financial Results on November 13, 2025 [Yahoo! Finance]
Medium
Report
Omeros Corporation to Announce Third Quarter Financial Results on November 13, 2025 [Yahoo! Finance]
11/11
08:30 am
omer
Omeros Corporation to Announce Third Quarter Financial Results on November 13, 2025
Medium
Report
Omeros Corporation to Announce Third Quarter Financial Results on November 13, 2025
10/17
04:44 pm
omer
Omeros: Novo Nordisk Deal Highlights MASP-3 Alternative Pathway Targeting [Seeking Alpha]
Low
Report
Omeros: Novo Nordisk Deal Highlights MASP-3 Alternative Pathway Targeting [Seeking Alpha]
10/16
10:10 am
omer
Omeros: Novo Nordisk's Licensing Deal Sends Shares Soaring, Makes Bull Case [Seeking Alpha]
Low
Report
Omeros: Novo Nordisk's Licensing Deal Sends Shares Soaring, Makes Bull Case [Seeking Alpha]
10/16
08:30 am
omer
Omeros Announces Publication Highlighting Survival Benefits in TA-TMA Patients Treated with Narsoplimab Versus a Well-Matched External Control Group
Medium
Report
Omeros Announces Publication Highlighting Survival Benefits in TA-TMA Patients Treated with Narsoplimab Versus a Well-Matched External Control Group
10/15
01:48 pm
omer
Omeros (NASDAQ:OMER) had its "hold" rating reaffirmed by analysts at Needham & Company LLC.
Medium
Report
Omeros (NASDAQ:OMER) had its "hold" rating reaffirmed by analysts at Needham & Company LLC.
10/15
12:30 pm
omer
Omeros (NASDAQ:OMER) had its price target raised by analysts at HC Wainwright from $9.00 to $20.00. They now have a "buy" rating on the stock.
Low
Report
Omeros (NASDAQ:OMER) had its price target raised by analysts at HC Wainwright from $9.00 to $20.00. They now have a "buy" rating on the stock.
10/15
12:30 pm
omer
Omeros (NASDAQ:OMER) had its "strong-buy" rating reaffirmed by analysts at WBB Securities. They now have a $45.00 price target on the stock.
Low
Report
Omeros (NASDAQ:OMER) had its "strong-buy" rating reaffirmed by analysts at WBB Securities. They now have a $45.00 price target on the stock.
10/15
09:51 am
omer
Omeros (NASDAQ:OMER) had its "buy" rating reaffirmed by analysts at D. Boral Capital. They now have a $36.00 price target on the stock.
Medium
Report
Omeros (NASDAQ:OMER) had its "buy" rating reaffirmed by analysts at D. Boral Capital. They now have a $36.00 price target on the stock.
9/20
01:09 am
omer
Low
Report